Paxlovid Rebound: FDA Investigating Reports Of Covid-19 Relapses After Taking Pfizer Antiviral
For example, there’s that pre-print case report uploaded to Research Square on April 26, 2022, of a 71-year-old man who had been fully vaccinated and boosted against Covid-19. He began taking Paxlovid as soon as he had tested positive for Covid-19, two days after he had gotten exposed to the virus. His Covid-19 symptoms essentially disappeared after two days of Paxlovid, which seemed like a good thing. Yet, nine days after he had first tested positive and four days after he had completed the five-day course of Paxlovid, guess what happened? His runny nose, sore throat, and difficulty breathing returned, along with SARS-CoV-2 levels in his body going up again. It was like déjà eww all over again. Viral genome sequencing showed that during both his initial symptoms and his return of symptoms, he was infected with the BA.1 Omicron subvariant of the SARS-CoV-2. This suggested that he has experienced not two separate infections but a single one that improved before subsequently getting worse.
Forbes - May 20, 2022View the full story here: https://www.forbes.com/sites/brucelee/2022/05/19/paxlovid-rebound-some-suffering-covid-19-relapses-after-taking-pfizer-antiviral/